Current applications of nanoparticles in infectious diseases

H Zazo, CI Colino, JM Lanao - Journal of Controlled Release, 2016 - Elsevier
For decades infections have been treated easily with drugs. However, in the 21st century,
they may become lethal again owing to the development of antimicrobial resistance …

Nano-therapeutics: A revolution in infection control in post antibiotic era

S Zaidi, L Misba, AU Khan - Nanomedicine: Nanotechnology, Biology and …, 2017 - Elsevier
With the arrival of antibiotics 70 years ago, meant a paradigm shift in overcoming infectious
diseases. For decades, drugs have been used to treat different infections. However, with …

Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular …

R Bhowmik, R Kant, A Manaithiya, D Saluja… - Frontiers in …, 2023 - frontiersin.org
Mycobacterium tuberculosis is the bacterial strain that causes tuberculosis (TB). However,
multidrug-resistant and extensively drug-resistant tuberculosis are significant obstacles to …

Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of …

N Kumar, R Srivastava, A Prakash… - Journal of Biomolecular …, 2020 - Taylor & Francis
The nitrate/nitrite response regulatory protein NarL belongs to the two-component regulatory
system of Mycobacterium tuberculosis (MTB), plays a crucial role in anaerobic survival of …

Carbon nanotropes: a contemporary paradigm in drug delivery

AC Tripathi, SA Saraf, SK Saraf - Materials, 2015 - mdpi.com
Discovery of fullerenes and other nanosized carbon allotropes has opened a vast new field
of possibilities in nanotechnology and has become one of the most promising research …

Synthesis of exfoliated multilayer graphene and its putative interactions with SARS-CoV-2 virus investigated through computational studies

B Raval, AK Srivastav, SK Gupta, U Kumar… - Journal of …, 2022 - Taylor & Francis
Our work investigates the interaction of synthesized graphene with the SARS-CoV-2 virus
using molecular docking and molecular dynamics (MD) simulation method. The layer …

Enhancing cancer drug development with xanthone derivatives: A QSAR approach and comparative molecular docking investigations

BB Gohain, U Gogoi, A Das, S Rajkhowa - South African Journal of Botany, 2023 - Elsevier
Xanthone compounds are known to have diverse pharmacological activities, including anti-
inflammatory, anticancer properties. However, they face challenges such as poor water …

Revelation of enzyme activity of mutant pyrazinamidases from Mycobacterium tuberculosis upon binding with various metals using quantum mechanical approach

N Rasool, W Husssain, YD Khan - Computational biology and chemistry, 2019 - Elsevier
Pyrazinamide (PZA) is one of the most potent bacteriostatic drug against tuberculosis, a
deadliest disease with high mortality and morbidity rate. PZA metabolizes into its active form …

Carbon nanomaterials: a new way against tuberculosis

F De Maio, V Palmieri, M De Spirito… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Tuberculosis (TB) remains one of the most alarming worldwide infectious
diseases primarily in low-income countries, where the infection shows a higher and …

Density functional study on noncovalent functionalization of pyrazinamide chemotherapeutic with graphene and its prototypes

N Saikia, RC Deka - New Journal of Chemistry, 2014 - pubs.rsc.org
We perform density functional studies to comprehend the structure and energetics of the
interaction of the drug pyrazinamide (PZA) with graphene-based nanomaterials using a …